Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
TH211 Probe Info |
![]() |
Y218(7.33); Y191(6.17) | LDD0260 | [1] | |
IA-alkyne Probe Info |
![]() |
N.A. | LDD0036 | [2] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Other
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1) | PI3K p85 subunit family | P27986 |
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Belatacept | . | D0N4HB |
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Ab-103 | Small molecular drug | D04HQJ |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Regn5678 | Antibody | D8UZM7 | |||
Au101 | . | D0T9JW | |||
Lulizumab Pegol | . | D0GB5X |
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Sar442257 | Antibody | DBP9Q5 | |||
Cd19-car And Cd28-car T Cells | CAR T Cell Therapy (Dual specific) | D0QE4F | |||
Cd28 And Cd137 Car-t Cells | CAR T Cell Therapy (Dual specific) | D0JY0M |
Investigative
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Anti-cd28 | Antibody | D0V9LF | |||
Fr-104 | Antibody | D0A2MA |
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Tgn-1412 | Antibody | D00PNU |
References